3-24-2023 – Exela Pharma Sciences to support hospital’s new inpatient pharmacy
March 25, 2023 | Comments Off on 3-24-2023 – Exela Pharma Sciences to support hospital’s new inpatient pharmacy

BY NEWS-TOPIC STAFF LENOIR – The Exela Pharma Sciences Inpatient Pharmacy will be a part of UNC Health Caldwell’s planned $33+ million expansion, the hospital announced Friday. “We’re proud to be able to support our local hospital,” said Phanesh Koneru, founder and CEO of Exela Pharma Sciences. “The new inpatient pharmacy is very aligned with Exela’s focus on delivering excellence in quality and reliability.” Last renovated in 1983, the current inpatient pharmacy is undersized and lacks the equipment and space needed to provide the expanded scope of services UNC Health Caldwell offers today. “The pharmacy department has expanded services, regulations
Read More

EXELA Pharma Sciences Commences Patent Infringement Litigation Against Nivagen on ELCYS (cysteine)</strong>
February 6, 2023 | Comments Off on EXELA Pharma Sciences Commences Patent Infringement Litigation Against Nivagen on ELCYS (cysteine)

Lenoir, NC February 6, 2023 – Exela Pharma Sciences, LLC (“Exela”) has commenced patent infringement litigation today against Nivagen Pharmaceuticals, Inc. (“Nivagen”) in the United States District Court for the District of Delaware to prevent unauthorized launch of its recently approved 7.25% L-Cysteine injection drug product. Exela believes Nivagen’s product infringes one or more of Exela’s patents covering Exela’s pioneering work in developing low-aluminum L-Cysteine injection products. Exela seeks among other remedies a temporary restraining order and an injunction. About Exela Pharma SciencesExela Pharma Sciences, a fast-growing US based integrated specialty pharmaceutical company, focuses on developing, manufacturing and marketing proprietary
Read More

COVID-19 RESPONSE AND STATUS UPDATE AT EXELA PHARMA SCIENCES
June 29, 2020 | Comments Off on COVID-19 RESPONSE AND STATUS UPDATE AT EXELA PHARMA SCIENCES

JUNE 29, 2020 – Like many essential businesses, we at Exela have been impacted by COVID. Those who tested positive are recovering at home. We continue to monitor the matter, follow CDC recommendations regarding care and prevention, and explore ways to further reduce risk including urging our employees to be mindful of their activities outside of the workplace to reduce their risk of bringing the virus into our facilities. During this pandemic, Exela has not taken lightly its role to protect its employees, their families, or the communities in which we live. Indeed, we have kept abreast of the changing
Read More